SightfileU.S. market data from official filings

ANIKA THERAPEUTICS INC (ANIK)

Name: ANIKA THERAPEUTICS INC (ANIK) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000898437 · EDGAR filings · Updated 2026-07-17

ANIKA THERAPEUTICS INC (ANIK) has reported institutional ownership of 92.9%, with 129 institutional managers holding positions valued at $179.1M per the latest 13F reporting period.

Institutional ownership

92.9%

Institutional managers

129

Reported 13F value

$179.1M

Insider activity

34 trans.

$0 net flat

Latest updates

2026-07-17 — SCHEDULE 13G/A filed
2026-07-14 — Current report (8-K) filed
2026-06-23 — Insider transaction reported (Form 4)
2026-06-23 — Insider transaction reported (Form 4)
2026-06-23 — Insider transaction reported (Form 4)
2026-06-23 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ANIKA THERAPEUTICS INC has 129 institutional holders and institutional ownership of 92.9%.

Insider activity

Insiders reported 34 transactions (0 buys, 0 sells) across 12 reporting insiders, with a net reported value of $0.

Related companies

AUTOLUS THERAPEUTICS LTD (AUTL) · SIGA TECHNOLOGIES INC (SIGA) · USANA HEALTH SCIENCES INC (USNA) · ABEONA THERAPEUTICS INC (ABEO) · LINEAGE CELL THERAPEUTICS IN (LCTX) · CAMP4 THERAPEUTICS CORP (CAMP)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-17.